Industries > Pharma > Global Treatment for Neglected Tropical Disease Market 2019-2029

Global Treatment for Neglected Tropical Disease Market 2019-2029

Malaria, Dengue, Leishmaniasis, Schistosomiasis, Lymphatic Filariasis, Chagas Disease

PAGES: 157
PRODUCT CODE: PHA0396

Clear
WOOCS 2.2.1
SKU: PHA0240 Categories: , , Tag:

The Global Treatment for Neglected Tropical Disease market is expected to grow at a CAGR of 7.3% in the second half of the forecast period. The Global Treatment for Neglected Tropical Disease market reached $1.5bn in 2016, dominated by the treatments for malaria which held 30% share of the market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 157-page report you will receive 71 tables and 80 figures– all unavailable elsewhere.

The 157-page report provides clear detailed insight into the Global Treatment for Neglected Tropical Disease market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

Global Treatment for Neglected Tropical Disease market forecasts from 2019-2029

Global Treatment for Neglected Tropical Disease Market 2017-2027

• This report also breaks down the revenue forecast for the Global Treatment for Neglected Tropical Disease market by disease type:
– Malaria treatments
– Dengue treatments
– Leishmaniasis
– Schistosomiasis
– Lymphatic Filariasis
– Chagas Disease
– Others

For each disease type, the report provides a SWOT analysis, a list of selected drugs and revenue forecasts from 2019-2029 of the leading drugs.

• This report provides revenue forecast for these leading drugs:
– Coartem (Novartis)
– Clindamycin (Pfizer)
– Dengvaxia (Sanofi)
– AmBisome (Gilead Sciences)
– Impavido (Knight Therapeutics)
– ALBENZA (Amedra Pharmaceuticals LLC)

• This report also breaks down the revenue forecast for the Global Treatment for Neglected Tropical Disease market by regional and national market:
– North America: US and Canada
– Europe: Germany, the UK, France, Spain, Italy, Rest of Europe
– Asia-Pacific: Japan, China, India, Rest of Asia
– Latin America: Brazil, Mexico, Rest of Latin America
– Middle East & Africa: Saudi Arabia, South of Africa, Rest of Middle East & Africa

Each regional market is further broken down by disease type.

• This report provides company overview, financial information, product portfolio and recent developments for the leading companies in the neglected tropical disease market:
– Pfizer, Inc.
– Bayer
– GlaxoSmithKline plc
– Merck & Co., Inc.
– Novartis International AG
– Takeda Pharmaceutical Company Ltd
– Sanofi S.A.
– Eisai Co., Ltd

Buy our report today Global Treatment for Neglected Tropical Disease Market 2019-2029: Malaria, Dengue, Leishmaniasis, Schistosomiasis, Lymphatic Filariasis, Chagas Disease.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Treatment for Neglected Tropical Disease Market 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Global Treatment for Neglected Tropical Disease Market 2019-2029


Latest Pharma news

Visiongain Publishes Nasal Drug Delivery Technology Market Report 2022-2032

The nasal drug delivery market will expand rapidly due to rising patient preference for nasal medication delivery due to ease of administration and efficacy, increased self-administration practises, and increased demand for home healthcare equipment.

18 January 2022

READ

Visiongain Publishes Deep Frozen Packaging Logistics Market Report 2022-2032

The desire for various types of medications to assist combat a growing number of chronic diseases & lifestyle-related ailments is fuelling the overall deep freeze packaging logistics market demand.

14 January 2022

READ

Visiongain Publishes Pre-Filled Syringes Market Report 2022-2032

With COVID-19 pandemic, the prefilled syringes business has witnessed a significant growth. Since the outbreak of the pandemic, global market players involved in the development of the prefilled syringes market across the globe have increased their investment in raw materials and resources owing to the rise in demand for home based healthcare services.

11 January 2022

READ

Visiongain Publishes Single-use Bioprocessing Probes & Sensors Market Report 2022-2032

To promote their organic revenue growth and market presence, the top companies are pursuing different strategic initiatives such as OEM collaborations and new product development with better technological intricacy.

05 January 2022

READ

Categories